Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

To evaluate the efficacy and safety of an oxaliplatin, fluorouracil (5-FU), and folinic acid (FA) combination in patients with metastatic or advanced gastric cancer (M/AGC). Of the 54 eligible patients with measurable or assessable M/AGC, 53 received oxaliplatin 100 mg/m(2) and FA 400 mg/m(2) (2-hou...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 20; no. 23; p. 4543
Main Authors:	Louvet, C, André, T, Tigaud, J M, Gamelin, E, Douillard, J Y, Brunet, R, François, E, Jacob, J H, Levoir, D, Taamma, A, Rougier, P, Cvitkovic, E, de Gramont, A
Format:	Journal Article
Language:	English
Published:	United States 01.12.2002
Subjects:	Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Drug Administration Schedule Female Fluorouracil - administration & dosage Humans Leucovorin - administration & dosage Male Middle Aged Organoplatinum Compounds - administration & dosage Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Survival Analysis Treatment Outcome
ISSN:	0732-183X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!